30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Axsome Therapeutics Inc (AXSM)

Track

Over the last 90 days, Axsome Therapeutics Inc. has seen significant insider selling activity, with total sales exceeding $54.8 million. Notably, several directors and officers, including the CEO and CFO, have engaged in planned and proposed sales. This activity occurred despite a strong 90-day stock price increase of over 60%. The last earnings report showed a miss.
Stock chart
Ticker: AXSM Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
JEFFS ROGER
4 sales — total 400,000 USD
Planned sale 11 Jun 2026
Value US$3,113,341.16 | Price 98.26 | Shares 77,391
Planned sale 11 Jun 2026
Value US$4,959,477.68 | Price 198.61 | Shares 13,339
Planned sale 11 Jun 2026
Value US$100,000.00 | Price 249.12 | Shares 1,000
Proposed sale 11 Jun 2026
Value US$100,000.00 | Price 249.12 | Shares 1,000
Planned sale 10 Jun 2026
Value US$3,125,664.48 | Price 401.58 | Shares 21,839
Proposed sale 10 Jun 2026
Value US$3,742,591.45 | Price 151.22 | Shares 97,124
Planned sale 10 Jun 2026
Value US$100,000.00 | Price 246.18 | Shares 1,000
Planned sale 10 Jun 2026
Value US$100,000.00 | Price 246.18 | Shares 1,000
Proposed sale 10 Jun 2026
Value US$100,000.00 | Price 246.18 | Shares 1,000
Planned sale 10 Jun 2026
Value US$100,000.00 | Price 249.00 | Shares 1,000
Planned sale 10 Jun 2026
Value US$100,000.00 | Price 249.00 | Shares 1,000
Proposed sale 10 Jun 2026
Value US$100,000.00 | Price 249.00 | Shares 1,000
Planned sale 9 Jun 2026
Value US$100,000.00 | Price 237.21 | Shares 1,000
Planned sale 9 Jun 2026
Value US$100,000.00 | Price 237.21 | Shares 1,000
Proposed sale 9 Jun 2026
Value US$100,000.00 | Price 237.21 | Shares 1,000
Planned sale 9 Jun 2026
Value US$100,000.00 | Price 241.01 | Shares 1,000
Proposed sale 9 Jun 2026
Value US$100,000.00 | Price 245.64 | Shares 1,000
Planned sale 9 Jun 2026
Value US$100,000.00 | Price 240.09 | Shares 1,000
Proposed sale 9 Jun 2026
Value US$100,000.00 | Price 240.09 | Shares 1,000
Planned sale 2 Jun 2026
Value US$1,236,910.43 | Price 223.39 | Shares 5,537
Proposed sale 2 Jun 2026
Value US$1,236,885.00 | Price 223.39 | Shares 5,537
Planned sale 1 Jun 2026
Value US$1,381,800.00 | Price 230.30 | Shares 6,000
Proposed sale 1 Jun 2026
Value US$1,381,798.00 | Price 230.30 | Shares 6,000
Planned sale 29 May 2026
Value US$1,400,760.00 | Price 233.46 | Shares 6,000
Proposed sale 29 May 2026
Value US$1,400,783.00 | Price 233.46 | Shares 6,000
Planned sale 5 May 2026
Value US$53,165.94 | Price 228.18 | Shares 233
Proposed sale 5 May 2026
Value US$51,972.98 | Price 223.06 | Shares 233
Planned sale 4 May 2026
Value US$1,029,604.98 | Price 227.94 | Shares 4,517
Proposed sale 4 May 2026
Value US$1,010,452.90 | Price 223.70 | Shares 4,517
Proposed sale 4 May 2026
Value US$1,010,452.90 | Price 223.70 | Shares 4,517
Planned sale 22 Apr 2026
Value US$1,368,150.00 | Price 182.42 | Shares 7,500
Proposed sale 22 Apr 2026
Value US$1,368,151.00 | Price 182.42 | Shares 7,500
Planned sale 26 Feb 2026
Value US$4,027,750.00 | Price 161.11 | Shares 25,000
Proposed sale 26 Feb 2026
Value US$4,027,636.00 | Price 161.11 | Shares 25,000
Planned sale 26 Feb 2026
Value US$5,726,990.64 | Price 161.88 | Shares 35,378
Proposed sale 26 Feb 2026
Value US$5,773,335.82 | Price 163.19 | Shares 35,378
Proposed sale 2 Feb 2026
Value US$6,024,370.80 | Price 185.88 | Shares 32,410
Planned sale 2 Feb 2026
Value US$6,015,296.00 | Price 185.60 | Shares 32,410
Planned sale 22 Jan 2026
Value US$2,255,040.00 | Price 187.92 | Shares 12,000
Proposed sale 22 Jan 2026
Value US$2,254,989.00 | Price 187.92 | Shares 12,000
Planned sale 21 Jan 2026
Value US$1,383,300.00 | Price 184.44 | Shares 7,500
Proposed sale 21 Jan 2026
Value US$1,383,327.00 | Price 184.44 | Shares 7,500
Proposed sale 7 Jan 2026
Value US$5,335,940.09 | Price 170.69 | Shares 31,261
Planned sale 7 Jan 2026
Value US$5,326,249.18 | Price 170.38 | Shares 31,261
Planned sale 6 Jan 2026
Value US$5,075,118.50 | Price 172.33 | Shares 29,450
Proposed sale 6 Jan 2026
Value US$5,061,866.00 | Price 171.88 | Shares 29,450
Planned sale 5 Jan 2026
Value US$13,480,249.84 | Price 171.28 | Shares 78,703
Proposed sale 5 Jan 2026
Value US$13,496,777.47 | Price 171.49 | Shares 78,703
Planned sale 31 Dec 2025
Value US$5,177,732.28 | Price 165.18 | Shares 31,346
Planned sale 31 Dec 2025
Value US$1,029,236.58 | Price 165.18 | Shares 6,231
Proposed sale 4 Dec 2025
Value US$1,563,006.32 | Price 148.04 | Shares 10,558
Planned sale 4 Dec 2025
Value US$1,564,484.44 | Price 148.18 | Shares 10,558
Planned sale 3 Dec 2025
Value US$2,962,751.22 | Price 146.94 | Shares 20,163
Proposed sale 3 Dec 2025
Value US$2,980,293.03 | Price 147.81 | Shares 20,163
Planned sale 2 Dec 2025
Value US$7,121,346.68 | Price 144.59 | Shares 49,252
Proposed sale 2 Dec 2025
Value US$6,998,216.68 | Price 142.09 | Shares 49,252
Proposed sale 5 Nov 2025
Value US$2,954,649.75 | Price 135.69 | Shares 21,775
Planned sale 5 Nov 2025
Value US$2,928,519.75 | Price 134.49 | Shares 21,775
Planned sale 4 Nov 2025
Value US$6,750,909.61 | Price 133.79 | Shares 50,459
Proposed sale 4 Nov 2025
Value US$6,808,432.87 | Price 134.93 | Shares 50,459
Planned sale 3 Nov 2025
Value US$12,136,239.70 | Price 132.34 | Shares 91,705
Proposed sale 3 Nov 2025
Value US$12,448,953.75 | Price 135.75 | Shares 91,705
Proposed sale 8 Oct 2025
Value US$1,516,401.54 | Price 118.71 | Shares 12,774
Planned sale 8 Oct 2025
Value US$1,518,062.16 | Price 118.84 | Shares 12,774
Planned sale 7 Oct 2025
Value US$1,590,330.30 | Price 118.77 | Shares 13,390
Proposed sale 7 Oct 2025
Value US$1,588,589.60 | Price 118.64 | Shares 13,390
Planned sale 6 Oct 2025
Value US$2,309,667.40 | Price 120.17 | Shares 19,220
Proposed sale 6 Oct 2025
Value US$2,305,246.80 | Price 119.94 | Shares 19,220
Proposed sale 22 Sep 2025
Value US$1,159,571.00 | Price 115.96 | Shares 10,000
Planned sale 22 Sep 2025
Value US$1,159,600.00 | Price 115.96 | Shares 10,000
Planned sale 16 Sep 2025
Value US$4,569,200.00 | Price 114.23 | Shares 40,000
Planned sale 16 Sep 2025
Value US$671,926.77 | Price 116.19 | Shares 5,783
Proposed sale 16 Sep 2025
Value US$5,241,305.00 | Price 114.48 | Shares 45,783
Proposed sale 16 Sep 2025
Value US$2,249,937.90 | Price 114.10 | Shares 19,719
Planned sale 16 Sep 2025
Value US$2,251,712.61 | Price 114.19 | Shares 19,719
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-11 2026-06-11 PlS Planned sale
2.4
JEFFS ROGER
Non-Executive Director
77,391 +34.5%
98.26
US$3,113,341 		77,391 +34.5% 98.26 US$3,113,341
2026-06-11 2026-06-11 PlS Planned sale
2.4
JEFFS ROGER
Non-Executive Director
13,339 +21.9%
198.61
US$4,959,478 		13,339 +21.9% 198.61 US$4,959,478
2026-06-11 2026-06-11 PlS Planned sale
2.4
JEFFS ROGER
Non-Executive Director
94,426 -44.5%
273.27
US$4,779,563 		94,426 -44.5% 273.27 US$4,779,563
2026-06-11 2026-06-11 PrS Proposed sale
2.4
JEFFS ROGER

Director

Non-Executive Director
1,000
249.12
US$100,000 		1,000 249.12 US$100,000
2026-06-11 2026-06-10 PlS Planned sale
2.4
JEFFS ROGER
Non-Executive Director
1,000 -0.5%
246.18
US$100,000 		1,000 -0.5% 246.18 US$100,000
2026-06-10 2026-06-10 PlS Planned sale
Mahony Susan
Non-Executive Director
1,000 -26.6%
246.18
US$100,000 		1,000 -26.6% 246.18 US$100,000
2026-06-10 2026-06-10 PlS Planned sale
3.5
Coleman Mark
Non-Executive Director
1,000 -2.1%
249.00
US$100,000 		1,000 -2.1% 249.00 US$100,000
2026-06-10 2026-06-10 PlS Planned sale
Mahony Susan
Non-Executive Director
1,000 -26.6%
246.18
US$100,000 		1,000 -26.6% 246.18 US$100,000
2026-06-10 2026-06-10 PlS Planned sale
3.5
Coleman Mark
Non-Executive Director
1,000 -2.1%
249.00
US$100,000 		1,000 -2.1% 249.00 US$100,000
2026-06-10 2026-06-10 PrS Proposed sale
3.5
Coleman Mark

Director

Non-Executive Director
1,000
249.00
US$100,000 		1,000 249.00 US$100,000
2026-06-10 2026-06-10 PrS Proposed sale
Mahony Susan

Director

Non-Executive Director
1,000
246.18
US$100,000 		1,000 246.18 US$100,000
2026-06-10 2026-06-10 PrS Proposed sale
2.4
JEFFS ROGER

Director

Non-Executive Director
1,000
246.18
US$100,000 		1,000 246.18 US$100,000
2026-06-10 2026-06-09 PlS Planned sale
Mahony Susan
Non-Executive Director
1,000 -21.0%
237.21
US$100,000 		1,000 -21.0% 237.21 US$100,000
2026-06-10 2026-06-09 PlS Planned sale
Mahony Susan
Non-Executive Director
1,000 -21.0%
237.21
US$100,000 		1,000 -21.0% 237.21 US$100,000
2026-06-09 2026-06-09 PlS Planned sale
TABUTEAU HERRIOT

Chief Executive Officer

Executive Director Large shareholder
1,000 -87.3%
241.01
US$100,000 		1,000 -87.3% 241.01 US$100,000
2026-06-09 2026-06-09 PrS Proposed sale
Herriot Tabuteau

Officer

Officer
1,000
245.64
US$100,000 		1,000 245.64 US$100,000
2026-06-09 2026-06-09 PlS Planned sale
3.9
Pizzie Nick

Chief Financial Officer

Officer
1,000 -43.5%
240.09
US$100,000 		1,000 -43.5% 240.09 US$100,000
2026-06-09 2026-06-09 PrS Proposed sale
Mahony Susan

Director

Non-Executive Director
1,000
237.21
US$100,000 		1,000 237.21 US$100,000
2026-06-09 2026-06-09 PrS Proposed sale
3.9
Pizzie Nick

Officer

Officer
1,000
240.09
US$100,000 		1,000 240.09 US$100,000
2026-06-02 2026-06-02 PlS Planned sale
3.5
Coleman Mark
Non-Executive Director
5,537 -15.8%
223.39
US$1,236,910 		5,537 -15.8% 223.39 US$1,236,910
2026-06-02 2026-06-02 PrS Proposed sale
3.5
Coleman Mark

Director

Non-Executive Director
5,537
223.39
US$1,236,885 		5,537 223.39 US$1,236,885
2026-06-02 2026-06-01 PlS Planned sale
3.5
Coleman Mark
Non-Executive Director
6,000 -14.6%
230.30
US$1,381,800 		6,000 -14.6% 230.30 US$1,381,800
2026-06-01 2026-06-01 PrS Proposed sale
3.5
Coleman Mark

Director

Non-Executive Director
6,000
230.30
US$1,381,798 		6,000 230.30 US$1,381,798
2026-06-02 2026-05-29 PlS Planned sale
3.5
Coleman Mark
Non-Executive Director
6,000 -12.7%
233.46
US$1,400,760 		6,000 -12.7% 233.46 US$1,400,760
2026-05-29 2026-05-29 PrS Proposed sale
3.5
Coleman Mark

Director

Non-Executive Director
6,000
233.46
US$1,400,783 		6,000 233.46 US$1,400,783
2026-05-05 2026-05-05 PlS Planned sale
0.7
Jacobson Mark L.

Chief Operating Officer

Officer
233 -100.0%
228.18
US$53,166 		233 -100.0% 228.18 US$53,166
2026-05-05 2026-05-05 PrS Proposed sale
0.7
Mark Jacobson

Officer

Officer
233
223.06
US$51,973 		233 223.06 US$51,973
2026-05-05 2026-05-04 PlS Planned sale
0.7
Jacobson Mark L.

Chief Operating Officer

Officer
4,517 -100.0%
227.94
US$1,029,605 		4,517 -100.0% 227.94 US$1,029,605
2026-05-05 2026-05-04 PrS Proposed sale
0.7
Mark Jacobson

Officer

Officer
4,517
223.70
US$1,010,453 		4,517 223.70 US$1,010,453
2026-05-04 2026-05-04 PrS Proposed sale
0.7
Mark Jacobson

Officer

Officer
4,517
223.70
US$1,010,453 		4,517 223.70 US$1,010,453
2026-04-23 2026-04-22 PlS Planned sale
Maizel Ari

Chief Commercial Officer

Officer
7,500 -100.0%
182.42
US$1,368,150 		7,500 -100.0% 182.42 US$1,368,150
2026-04-22 2026-04-22 PrS Proposed sale
Maizel Ari

Officer

Officer
7,500
182.42
US$1,368,151 		7,500 182.42 US$1,368,151
2026-02-27 2026-02-26 PlS Planned sale
3.5
Coleman Mark
Non-Executive Director
25,000 -34.7%
161.11
US$4,027,750 		25,000 -34.7% 161.11 US$4,027,750
2026-02-27 2026-02-26 PlS Planned sale
0.7
Jacobson Mark L.

Chief Operating Officer

Officer
35,378 -100.0%
161.88
US$5,726,991 		35,378 -100.0% 161.88 US$5,726,991
2026-02-26 2026-02-26 PrS Proposed sale
0.7
Mark Jacobson

Officer

Officer
35,378
163.19
US$5,773,336 		35,378 163.19 US$5,773,336
2026-02-26 2026-02-26 PrS Proposed sale
3.5
Coleman Mark

Director

Non-Executive Director
25,000
161.11
US$4,027,636 		25,000 161.11 US$4,027,636
2026-02-02 2026-02-02 PrS Proposed sale
Herriot Tabuteau

Officer

Officer
32,410
185.88
US$6,024,371 		32,410 185.88 US$6,024,371
2026-02-02 2026-02-02 PlS Planned sale
TABUTEAU HERRIOT

Chief Executive Officer

Executive Director Large shareholder
32,410 -81.8%
185.60
US$6,015,296 		32,410 -81.8% 185.60 US$6,015,296
2026-01-23 2026-01-22 PlS Planned sale
3.9
Pizzie Nick

Chief Financial Officer

Officer
12,000 -22.0%
187.92
US$2,255,040 		12,000 -22.0% 187.92 US$2,255,040
2026-01-22 2026-01-22 PrS Proposed sale
3.9
Pizzie Nick

Officer

Officer
12,000
187.92
US$2,254,989 		12,000 187.92 US$2,254,989
2026-01-23 2026-01-21 PlS Planned sale
Maizel Ari

Chief Commercial Officer

Officer
7,500 -100.0%
184.44
US$1,383,300 		7,500 -100.0% 184.44 US$1,383,300
2026-01-21 2026-01-21 PrS Proposed sale
Maizel Ari

Officer

Officer
7,500
184.44
US$1,383,327 		7,500 184.44 US$1,383,327
2026-01-07 2026-01-07 PrS Proposed sale
Herriot Tabuteau

Officer

Officer
31,261
170.69
US$5,335,940 		31,261 170.69 US$5,335,940
2026-01-07 2026-01-07 PlS Planned sale
TABUTEAU HERRIOT

Chief Executive Officer

Executive Director Large shareholder
31,261 -81.2%
170.38
US$5,326,249 		31,261 -81.2% 170.38 US$5,326,249
2026-01-07 2026-01-06 PlS Planned sale
TABUTEAU HERRIOT

Chief Executive Officer

Executive Director Large shareholder
29,450 -80.3%
172.33
US$5,075,118 		29,450 -80.3% 172.33 US$5,075,118
2026-01-06 2026-01-06 PrS Proposed sale
Herriot Tabuteau

Officer

Officer
29,450
171.88
US$5,061,866 		29,450 171.88 US$5,061,866
2026-01-07 2026-01-05 PlS Planned sale
TABUTEAU HERRIOT

Chief Executive Officer

Executive Director Large shareholder
78,703 -91.6%
171.28
US$13,480,250 		78,703 -91.6% 171.28 US$13,480,250
2026-01-05 2026-01-05 PrS Proposed sale
Herriot Tabuteau

Officer

Officer
78,703
171.49
US$13,496,777 		78,703 171.49 US$13,496,777
2026-01-02 2025-12-31 PlS Planned sale
2.9
Saad Mark E
Non-Executive Director
31,346 -75.8%
165.18
US$5,177,732 		31,346 -75.8% 165.18 US$5,177,732
2026-01-02 2025-12-31 PlS Planned sale
2.9
Saad Mark E
Non-Executive Director
6,231 -38.4%
165.18
US$1,029,237 		6,231 -38.4% 165.18 US$1,029,237
2025-12-04 2025-12-04 PrS Proposed sale
Herriot Tabuteau

Officer

Officer
10,558
148.04
US$1,563,006 		10,558 148.04 US$1,563,006
2025-12-04 2025-12-04 PlS Planned sale
TABUTEAU HERRIOT

Chief Executive Officer

Executive Director Large shareholder
10,558 -59.4%
148.18
US$1,564,484 		10,558 -59.4% 148.18 US$1,564,484
2025-12-04 2025-12-03 PlS Planned sale
TABUTEAU HERRIOT

Chief Executive Officer

Executive Director Large shareholder
20,163 -73.6%
146.94
US$2,962,751 		20,163 -73.6% 146.94 US$2,962,751
2025-12-03 2025-12-03 PrS Proposed sale
Herriot Tabuteau

Officer

Officer
20,163
147.81
US$2,980,293 		20,163 147.81 US$2,980,293
2025-12-04 2025-12-02 PlS Planned sale
TABUTEAU HERRIOT

Chief Executive Officer

Executive Director Large shareholder
49,252 -87.2%
144.59
US$7,121,347 		49,252 -87.2% 144.59 US$7,121,347
2025-12-02 2025-12-02 PrS Proposed sale
Herriot Tabuteau

Officer

Officer
49,252
142.09
US$6,998,217 		49,252 142.09 US$6,998,217
2025-11-05 2025-11-05 PrS Proposed sale
Herriot Tabuteau

Officer

Officer
21,775
135.69
US$2,954,650 		21,775 135.69 US$2,954,650
2025-11-05 2025-11-05 PlS Planned sale
TABUTEAU HERRIOT

Chief Executive Officer

Executive Director Large shareholder
21,775 -75.1%
134.49
US$2,928,520 		21,775 -75.1% 134.49 US$2,928,520
2025-11-05 2025-11-04 PlS Planned sale
TABUTEAU HERRIOT

Chief Executive Officer

Executive Director Large shareholder
50,459 -87.5%
133.79
US$6,750,910 		50,459 -87.5% 133.79 US$6,750,910
2025-11-04 2025-11-04 PrS Proposed sale
Herriot Tabuteau

Officer

Officer
50,459
134.93
US$6,808,433 		50,459 134.93 US$6,808,433
2025-11-05 2025-11-03 PlS Planned sale
TABUTEAU HERRIOT

Chief Executive Officer

Executive Director Large shareholder
91,705 -92.7%
132.34
US$12,136,240 		91,705 -92.7% 132.34 US$12,136,240
2025-11-03 2025-11-03 PrS Proposed sale
Herriot Tabuteau

Officer

Officer
91,705
135.75
US$12,448,954 		91,705 135.75 US$12,448,954
2025-10-08 2025-10-08 PrS Proposed sale
Herriot Tabuteau

Officer

Officer
12,774
118.71
US$1,516,402 		12,774 118.71 US$1,516,402
2025-10-08 2025-10-08 PlS Planned sale
TABUTEAU HERRIOT

Chief Executive Officer

Executive Director Large shareholder
12,774 -63.9%
118.84
US$1,518,062 		12,774 -63.9% 118.84 US$1,518,062
2025-10-08 2025-10-07 PlS Planned sale
TABUTEAU HERRIOT

Chief Executive Officer

Executive Director Large shareholder
13,390 -64.9%
118.77
US$1,590,330 		13,390 -64.9% 118.77 US$1,590,330
2025-10-07 2025-10-07 PrS Proposed sale
Herriot Tabuteau

Officer

Officer
13,390
118.64
US$1,588,590 		13,390 118.64 US$1,588,590
2025-10-08 2025-10-06 PlS Planned sale
TABUTEAU HERRIOT

Chief Executive Officer

Executive Director Large shareholder
19,220 -72.7%
120.17
US$2,309,667 		19,220 -72.7% 120.17 US$2,309,667
2025-10-06 2025-10-06 PrS Proposed sale
Herriot Tabuteau

Officer

Officer
19,220
119.94
US$2,305,247 		19,220 119.94 US$2,305,247
2025-09-22 2025-09-22 PrS Proposed sale
0.7
Jacobson Mark L.

Officer

Officer
10,000
115.96
US$1,159,571 		10,000 115.96 US$1,159,571
2025-09-22 2025-09-22 PlS Planned sale
0.7
Jacobson Mark L.

Chief Operating Officer

Officer
10,000 -100.0%
115.96
US$1,159,600 		10,000 -100.0% 115.96 US$1,159,600
2025-09-17 2025-09-16 PlS Planned sale
0.7
Jacobson Mark L.

Chief Operating Officer

Officer
40,000 -100.0%
114.23
US$4,569,200 		40,000 -100.0% 114.23 US$4,569,200
2025-09-17 2025-09-16 PlS Planned sale
0.7
Jacobson Mark L.

Chief Operating Officer

Officer
5,783 -100.0%
116.19
US$671,927 		5,783 -100.0% 116.19 US$671,927
2025-09-16 2025-09-16 PrS Proposed sale
Herriot Tabuteau

Officer

Officer
19,719
114.10
US$2,249,938 		19,719 114.10 US$2,249,938
2025-09-16 2025-09-16 PrS Proposed sale
0.7
Jacobson Mark L.

Officer

Officer
45,783
114.48
US$5,241,305 		45,783 114.48 US$5,241,305
2025-09-16 2025-09-16 PlS Planned sale
TABUTEAU HERRIOT

Chief Executive Officer

Executive Director Large shareholder
19,719 -73.2%
114.19
US$2,251,713 		19,719 -73.2% 114.19 US$2,251,713
Explore more

More insider trading research around Axsome Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America